Blog / Archives
Biotech Action Today is Muddled
Biotech Action Today is Muddled-Midday Selloff presumably on "Recycling" of China Trade Chatter Uncertainty Remains on Trade War and Tariffs Little rally in gene therapy stocks; 1% + Winners include...
Biotech had a Great October Boosted by Large Cap Biopharma Leader…Update-1 AMRN, REGN
Update-1 11/5 2p EST IBB flat, NAZ up 0.185, earnings from AMRN and REGN. Amarin down 3.5% to $16.83 on earnings but bulls are waiting for label expansion. Q3 Revenues are $112.4 M up 103%,...
Small Cap Picks Update: AMRN, GNMK, TDOC…Update-2
Update-2 Genmark (GNMK) down 3.6 % to $5.61 on Q3 results. Beat on revenue to $20.9 M up 32 % over prior quarter, loss of 20 cents/share.Waiting for a buy-out in 2020? Update-1 ...Nov....
Biotech Momentum Picks Up: CRSP MRK XBI…Updates 10/29,31.
Update 10/30 1:45 pm EDT Markets weak on China deal, PMI data Sold CRSP at $50.with 25% gain in 2 weeks; will get back in on weakness. XBI off 0.89%, IBB down 0.85%, NAZ off 0.44%. BMY up 1.5% near...
Biotech Snapshot on a Lackluster Day-ALXN, BMRN…Update-10/25
Update-1 10/25 at close...A Good Day on Low Volume-NASDAQ up 0.7%, S&P is up 20.56% YTD! Large caps mixed with IBB down a tad 0.29%;leaders are BIIB,BMY,RHHBY NASDAQ-100 at record high; QQQ up...
Bullish Trends in Biotech Today-Rebalance Portfolio with Healthcare…Update-1 Biogen
Update-1 10/22. Some follow through in biotech rally but sold off mirroring the NASDAQ about 2p,Maybe BREXIT related but we'll see later this week after many earnings reports. Large caps have been...
Surprisingly Strong Earnings Spark Healthcare Stocks : Time to Rebalance Your Portfolio…Update-1
Update-1 Large caps were mixed but our top picks are doing well: ABBV,BMY,MRK,RHHBY. But bad news from JNJ and BA may have curbed buyer's sentiment. United Health (UNH) off Mondays lows of $220 to...
Biotech Stocks Mired in Uncertainty: China Deal, Drug Pricing Politics and Earnings Outlook…Update-2 Rally Day
Update-2 10/13...Biotech IPOs Remain Weak-Recent rally was weak for small cap biotechs Vir Biotechnology (VIR): A clinical stage immunology and infectious disease Company focused on new therapies...
Large Cap Biopharma in Focus: Core Positions…Risk OFF…Updates
10/09/19 Better tape today but a lot of random churning and tactical trading, biopharma under siege? NASDAQ up 1.17%. Talk about mini-deal with China. Large cap leaders with IBB flat: REGN MRK BMY....
Biotech Snapshot: Bears Are Digging In…Update-2… Upside Reversal
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large...